Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Eclinicalmedicine|November 10, 2025
Nab-paclitaxel plus bevacizumab for patients with metastatic extrapulmonary neuroendocrine carcinoma: a phase 2 single-arm studyPanpan Zhang, Shengmian Li, Ru Jia, et al.Journal of Thoracic Disease|May 22, 2025
Association between reactive cutaneous capillary endothelial proliferation and the efficacy of camrelizumab in esophageal cancer: a retrospective cohort studyYuzi Qiu, Gelan Su, Lan Zhang, et al.Cell Death & Disease|December 6, 2019
Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinomaZhiming Dong, Shengmian Li, Xuan Wu, et al.Gastroenterology|February 13, 2021
Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal CarcinogenesisWeixin Liu, Xiang Zhang, Hongzhi Xu, et al.BMC Cancer|January 3, 2024
Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in ChinaWang Qu, Zimin Liu, Xiaobing Chen, et al.Signal Transduction and Targeted Therapy|June 21, 2026
Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, open-label phase 2 studyZhe Cao, Jiangdong Qiu, Wenhao Luo, et al.Cell Reports. Medicine|November 28, 2023
Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 studyBo Zhang, Yan Song, Suxia Luo, et al.Cancer Communications (London, England)|October 19, 2021
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II studyZhi Peng, Tianshu Liu, Jia Wei, et al.Pageof 3